Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain

被引:50
|
作者
Zanotti-Fregonara, Paolo [1 ,2 ]
Pascual, Belen [1 ,2 ]
Rizzo, Gaia [3 ,4 ]
Yu, Meixiang [1 ,2 ]
Pal, Neha [1 ,2 ]
Beers, David [1 ,2 ]
Carter, Randall [5 ]
Appel, Stanley H. [1 ,2 ]
Atassi, Nazem [6 ]
Masdeu, Joseph C. [1 ,2 ]
机构
[1] Houston Methodist Res Inst, Nantz Natl Alzheimer Ctr, Houston, TX USA
[2] Weill Cornell Med, Houston, TX USA
[3] Invicro, London, England
[4] Imperial Coll London, Dept Med, Div Brain Sci, London, England
[5] GE Global Res, Schenectady, NY USA
[6] Massachusetts Gen Hosp, Neurol Clin Res Inst, Boston, MA 02114 USA
关键词
C-11-PBR28; F-18-GE180; TSPO; POSITRON-EMISSION-TOMOGRAPHY; VIVO RADIOLIGAND BINDING; ASSESS RADIATION SAFETY; IN-VIVO; 18; KDA; PET RADIOLIGAND; TSPO PET; SUGGESTED PATHWAY; KINETIC-ANALYSIS; MODEL;
D O I
10.2967/jnumed.117.203109
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
F-18-GE180 is a third-generation PET tracer for quantifying the translocator protein (TSPO), a biomarker for inflammation. The aim of this study was to perform a head-to-head comparison of F-18-GE180 and the well-established TSPO tracer C-11-PBR28 by scanning with both tracers during the same day in the same subjects. Methods: Five subjects underwent a 90-min PET scan with C-11-PBR28 in the morning and F-18-GE180 in the afternoon. A metabolite-corrected arterial input function was obtained in each subject for both tracers, and the brain uptake was quantified with a 2-tissue-compartment model. Results: The rate of metabolism of F-18-GE180 in arterial blood was slower than that of C-11-PBR28 (the percentages of non-metabolized parent in plasma at 90 min were 74.9%+/- 4.15%[mean +/- SD] and 11.2% +/- 1.90%, respectively). The plasma free fractions were similar for both tracers: 3.5% +/- 1.1% for F-18-GE180 and 4.1% +/- 1.1% for C-11-PBR28. The average total volume of distribution (VT) of F-18-GE180 was about 20 times smaller than that of C-11-PBR28 (0.15 +/- 0.03 mL/cm(3) for F-18-GE180 and 3.27 +/- 0.66 mL/cm(3) for C-11-PBR28). F-18-GE180 was characterized by poor transfer from the vascular compartment to the brain (its plasma-to-tissue rate constant [K1] was about 10 times smaller than that of C-11-PBR28). Moreover, kinetic modeling was more difficult with F-18-GE180, as its VT values were identified with a lower precision than those of C-11-PBR28 and outlying values were more frequent. Conclusion: The VT of F-18-GE180 was about 20 times smaller than that of C-11-PBR28 because of low penetration into the brain from the vascular compartment. In addition, kinetic modeling of F-18-GE180 was more challenging than that of C-11-PBR28. Therefore, compared with C-11-PBR28, F-18-GE180 had unfavorable characteristics for TSPO imaging of the brain.
引用
收藏
页码:1260 / 1266
页数:7
相关论文
共 50 条
  • [31] Preclinical comparison with [18F]Fluoromethyl-PBR28-d2, [18F]Fluoromethyl-PBR28 and [11C]PBR28 as a potential radiotracer for TSPO
    Moon, B.
    Jung, J.
    Park, H.
    Lee, B.
    Kim, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S420 - S421
  • [32] Building a database for brain 18kDa translocator protein (TSPO) imaged using [11C]PBR28 in healthy subjects
    Paul, Soumen
    Liow, Jeih-San
    Gallagher, Evan
    Zoghbi, Sami
    Gunn, Roger
    Fregonara, Paolo Zanotti
    Morse, Cheryl
    Pike, Victor
    Innis, Robert
    Fujita, Masahiro
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [33] Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia
    Rowe, Christopher C.
    Pejoska, Svetlana
    Mulligan, Rachel S.
    Jones, Gareth
    Chan, J. Gordon
    Svensson, Samuel
    Cselenyi, Zsolt
    Masters, Colin L.
    Villemagne, Victor L.
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (06) : 880 - 886
  • [34] Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study
    Yang, Zhengshi
    Banks, Sarah J.
    Ritter, Aaron R.
    Cummings, Jeffrey L.
    Sreenivasan, Karthik
    Kinney, Jefferson W.
    Caldwell, Jessica K.
    Wong, Christina G.
    Miller, Justin B.
    Cordes, Dietmar
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 96 (04) : 1505 - 1514
  • [36] Serotonin 2A receptor agonist binding in the human brain with [11C] Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [18F] altanserin
    Ettrup, Anders
    Svarer, Claus
    McMahon, Brenda
    da Cunha-Bang, Sofi
    Lehel, Szabolcs
    Moller, Kirsten
    Dyssegaard, Agnete
    Ganz, Melanie
    Beliveau, Vincent
    Jorgensen, Louise Moller
    Gillings, Nic
    Knudsen, Gitte Moos
    NEUROIMAGE, 2016, 130 : 167 - 174
  • [37] Fully automated radiosynthesis of [11C]PBR28, a radiopharmaceutical for the translocator protein (TSPO) 18 kDa, using a GE TRACERlab FXC-Pro
    Hoareau, Raphael
    Shao, Xia
    Henderson, Bradford D.
    Scott, Peter J. H.
    APPLIED RADIATION AND ISOTOPES, 2012, 70 (08) : 1779 - 1783
  • [38] Correcting for the Ala147Thr polymorphism in the gene for 18 kDa translocator protein improves quantification of this inflammatory biomarker with [11C]PBR28
    Kreisl, William
    Jenko, Kimberly
    Hines, Christina
    Lyoo, Chul Hyoung
    Morse, Cheryl
    Zoghbi, Sami
    Kleinman, Joel
    Pike, Victor
    McMahon, Francis
    Innis, Robert
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 : S21 - S21
  • [39] Contribution of 18F-Fluorocholine PET/MRI in the postoperative follow-up of pituitary adenomas: head-to-head comparison with 11C-Methionine.
    Mathey, C.
    Spitaels, J.
    Trotta, N.
    Devuyst, F.
    Wetshosele, G. Omatuku
    Mabiglia, C.
    Goldman, S.
    Dewitte, O.
    Leurquin-Sterk, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S655 - S655
  • [40] Imaging of the 18 kDa translocator protein in an inflammation-prone mouse model using [11C]PBR28
    Lao, Patrick
    Hillmer, Ansel
    Barnhart, Todd
    Puglielli, Luigi
    Farhoud, Mohammed
    Christian, Bradley
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55